Coronary Embolism: Causes, Symptoms, Diagnosis, and Treatment

A coronary embolism occurs when a thrombus or other material (embolus) lodges in a coronary artery, abruptly obstructing blood flow to the myocardium. Unlike atherosclerotic plaque rupture (the typical cause of myocardial infarction), the embolic origin is often remote—making recognition and source identification critical.

Risk Factors & Etiologies

  • Cardiac sources: Atrial fibrillation (most common), left ventricular thrombus post-MI, valvular disease (mitral stenosis, prosthetic valves), infective endocarditis, atrial myxoma.
  • Procedural: Recent cardiac surgery, catheterization, PCI, TAVR.
  • Hypercoagulable states: Cancer (especially adenocarcinoma), antiphospholipid syndrome, factor V Leiden, postpartum.
  • Paradoxical embolism: Venous thrombus crossing a patent foramen ovale (PFO) or atrial septal defect.
  • Iatrogenic: Air, fat, or foreign material during procedures.

Clinical Presentation

Symptoms mirror acute coronary syndrome but may have distinctive features:

  • Sudden, severe chest pain/pressure (often at rest)
  • Dyspnea, diaphoresis, nausea
  • Syncope or presyncope (if large territory involved)
  • Signs of source: irregular pulse (AF), murmur (valvular), fever (endocarditis), DVT signs (paradoxical)

Diagnosis

  • ECG: ST-elevation or depression, T-wave changes corresponding to affected territory.
  • Troponin: Elevated, typically with rapid rise/fall pattern.
  • Coronary angiography: Reveals abrupt cutoff, often with normal proximal vessel; may visualize thrombus. Intravascular imaging (OCT/IVUS) can differentiate thrombus from plaque.
  • Source workup: TTE/TEE for cardiac source; lower extremity ultrasound for DVT; hypercoagulable panel if indicated.

Management

Acute Reperfusion

  • Thrombolysis: Consider if PCI unavailable; higher bleeding risk than in atherosclerotic MI.
  • Primary PCI with aspiration thrombectomy: Preferred; allows direct visualization, stenting if underlying plaque, and embolus retrieval for analysis.
  • CABG: For failed PCI, multivessel disease, or mechanical complications.

Antithrombotic Therapy

  • Dual antiplatelet therapy (DAPT) post-stent.
  • Anticoagulation tailored to source: DOAC/warfarin for AF, LV thrombus, hypercoagulable states; duration guided by etiology.

Source Control & Secondary Prevention

  • Rate/rhythm control for AF; valve surgery for endocarditis/severe valvular disease.
  • Cancer-directed therapy if malignancy-driven.
  • PFO closure considered in select paradoxical embolism cases.

Multidisciplinary coordination (cardiology, hematology, oncology) optimizes outcomes in this uncommon but high-stakes condition.

Cardiovascular Disease - Related Articles